Want to see AU:PGC full AI Analyst Report?
PGC Stock Chart & Stats
AU$0.17
-AU$0.01(-2.04%)
At close: 4:00 PM EST
AU$0.17
-AU$0.01(-2.04%)
Day’s Range― - ―
52-Week RangeAU$0.13 - AU$0.41
Previous CloseN/A
Volume365.08K
Average Volume (3M)501.29K
Market Cap
AU$264.85M
Enterprise ValueAU$673.44M
Total Cash (Recent Filing)AU$30.86M
Total Debt (Recent Filing)AU$464.29M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,655,305,400
10 Day Avg. Volume605,379
30 Day Avg. Volume501,285
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)1.90
Price to Sales (P/S)0.17
P/FCF Ratio-26.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.17Price Target Upside0.00%
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.02
Revenue Forecast (FY)AU$3.74B
Bulls Say, Bears Say
Bulls Say
Integrated Medical Distribution And ServicesParagon's combined product distribution and after-sales services create recurring service revenue and higher customer switching costs. Serving hospitals, labs and life-sciences clients builds durable demand and stickiness, supporting revenue stability and long-term customer relationships.
Manageable Leverage And Equity BaseA moderate debt-to-equity ratio and reasonable equity backing give the company financial flexibility to fund working capital and operational needs without excessive leverage. This balance helps absorb cyclical pressures and preserves capacity for targeted investments or restructuring.
Improving Operating MarginsIncremental EBIT/EBITDA margin gains indicate management focus on operational efficiency and cost control. If sustained, these improvements can enhance cash flow conversion and profitability resilience when top-line trends stabilize, supporting long-term margin sustainability.
Bears Say
Sharp Revenue DeclineA more than 20% revenue contraction materially reduces scale benefits and bargaining power with suppliers. Persisting top-line declines strain fixed-cost absorption, limit reinvestment capacity, and may signal structural demand or market-share issues that undermine medium-term recovery prospects.
Very Thin MarginsLow gross and net margins leave little buffer for cost inflation or pricing pressure given the distribution model. Sustained thin margins constrain free cash generation, limit strategic reinvestment, and increase vulnerability to competitive or supplier-driven margin compression over the coming months.
Negative Operating And Free Cash FlowPersistent negative operating and free cash flow undermines the firm's ability to fund working capital, capex and debt service from operations. Poor cash conversion and volatile FCF (high growth from negative base) increase refinancing and execution risks, reducing financial resilience.
Paragon Care Limited News
PGC FAQ
What was Paragon Care Limited’s price range in the past 12 months?
Paragon Care Limited lowest share price was AU$0.13 and its highest was AU$0.41 in the past 12 months.
What is Paragon Care Limited’s market cap?
Paragon Care Limited’s market cap is AU$264.85M.
When is Paragon Care Limited’s upcoming earnings report date?
Paragon Care Limited’s upcoming earnings report date is Aug 27, 2026 which is in 54 days.
How were Paragon Care Limited’s earnings last quarter?
Paragon Care Limited released its earnings results on Feb 24, 2026. The company reported -AU$1.29 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$1.29.
Is Paragon Care Limited overvalued?
According to Wall Street analysts Paragon Care Limited’s price is currently same.
Does Paragon Care Limited pay dividends?
Paragon Care Limited pays a Semiannually dividend of AU$0.006 which represents an annual dividend yield of N/A. See more information on Paragon Care Limited dividends here
What is Paragon Care Limited’s EPS estimate?
Paragon Care Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Paragon Care Limited have?
Paragon Care Limited has 1,655,305,400 shares outstanding.
What happened to Paragon Care Limited’s price movement after its last earnings report?
Paragon Care Limited reported an EPS of -AU$1.29 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.195%.
Which hedge fund is a major shareholder of Paragon Care Limited?
Currently, no hedge funds are holding shares in AU:PGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Paragon Care Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.17 (0.00% )
AU$0.17 (0.00% )
Blogger Sentiment
Bullish
AU:PGC Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$27.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.09%
12-Months-Change
Fundamentals
Return on Equity
-4.47%
Trailing 12-Months
Asset Growth
0.09%
Trailing 12-Months
Company Description
Paragon Care Limited
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems. In addition, the company offers aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; natural, traditional, and complementary health products and services; critical care and dental solutions; urology solutions, such as shockwave therapy, lasers, and accessories for infection control; medical products and consumables; and orthopaedics solutions, including hip and knee arthroplasty, upper and lower extremity, sports medicine, reverse shoulder replacement, and powered surgical tools. Further, it offers medical equipment repair, maintenance, and support services; technology and communication solutions, such as telephony, nurse call, access control, cctv, cordless, and Wi-Fi; supplies medical equipment to veterans, war widows, and families; and veterinary products. Additionally, it is involved in maintenance of technical medical equipment to the health, aged care, and veterinary markets; and distribution of pharmaceuticals, medical consumables, and complementary medicines to Australian healthcare market. The company is based in Mount Waverley, Australia.
PGC Stock 12 Month Forecast
Average Price Target
AU$0.17
▲(0.00% Upside)
Technical Analysis
Sigma Healthcare Ltd
―
Polynovo
―
Compumedics Limited
―
Epsilon Healthcare Limited
―
Trajan Group Holdings Ltd
―
Options Prices
Currently, No data available
---